Evidence map›Paper›PMID 30604225›Full record

ArticleActa neuropathologica2019

C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A.

Thomas G Moens, Teresa Niccoli, Katherine M Wilson, Magda L Atilano, Nicol Birsa, Lauren M Gittings, Benedikt V Holbling, Miranda C Dyson, Annora Thoeng, Jacob Neeves and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Brain communications · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Targeting GeneInternational journal of molecular sciences · 2025
    Review
  12. Review
  13. Article
  14. C9orf72-linked arginine-rich dipeptide repeats aggravate pathological phase separation of G3BP1.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 5 countries.

Thomas G MoensDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.ORCID 0000-0002-4783-6257
Teresa NiccoliDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Katherine M WilsonDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Magda L AtilanoDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Nicol BirsaSobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Lauren M GittingsDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Benedikt V HolblingDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Miranda C DysonDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Annora ThoengDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Jacob NeevesDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Idoia GlariaDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Lu YuWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Julia BussmannMolecular Neurogenetics Laboratory, Max Planck Institute for Molecular Biomedicine, 48149, Münster, Germany.
Erik StorkebaumMolecular Neurogenetics Laboratory, Max Planck Institute for Molecular Biomedicine, 48149, Münster, Germany.
Mercedes PardoWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Jyoti S ChoudharyWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Pietro FrattaMRC Centre for Neuromuscular Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Linda PartridgeDepartment of Genetics, Evolution and Environment, Institute of Healthy Ageing, UCL, Darwin Building, Gower Street, London, WC1E 6BT, UK. linda.partridge@ucl.ac.uk.
Adrian M IsaacsDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. a.isaacs@ucl.ac.uk.
UK Dementia Research Institute · GBInstitute of Cancer Research · GBNational Hospital for Neurology and Neurosurgery · GBAllen Institute for Brain Science · USMax Planck Institute for Biology of Ageing · DERadboud University Nijmegen · NLUniversity of Münster · DE

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
European Research Council 648716 - C9NDEuropean Research Council ERC-2017-COG 770244Medical Research Council MR/M008606/1Medical Research Council MR/S006508/1Motor Neurone Disease Association FRATTA/JAN15/946-795Motor Neurone Disease Association ISAACS/APR13/818-791NIH HHS P40 OD018537Wellcome TrustWellcome Trust WT098051
6 · The paper itself

Abstract

A GGGGCC hexanucleotide repeat expansion within the C9orf72 gene is the most common genetic cause of both amyotrophic lateral sclerosis and frontotemporal dementia. Sense and antisense repeat-containing transcripts undergo repeat-associated non-AUG-initiated translation to produce five dipeptide proteins (DPRs). The polyGR and polyPR DPRs are extremely toxic when expressed in Drosophila neurons. To determine the mechanism that mediates this toxicity, we purified DPRs from the Drosophila brain and used mass spectrometry to identify the in vivo neuronal DPR interactome. PolyGR and polyPR interact with ribosomal proteins, and inhibit translation in both human iPSC-derived motor neurons, and adult Drosophila neurons. We next performed a screen of 81 translation-associated proteins in GGGGCC repeat-expressing Drosophila to determine whether this translational repression can be overcome and if this impacts neurodegeneration. Expression of the translation initiation factor eIF1A uniquely rescued DPR-induced toxicity in vivo, indicating that restoring translation is a potential therapeutic strategy. These data directly implicate translational repression in C9orf72 repeat-induced neurodegeneration and identify eIF1A as a novel modifier of C9orf72 repeat toxicity.

Indexed as

Amyotrophic Lateral SclerosisAnimalsAnimals, Genetically ModifiedBrainC9orf72 ProteinDipeptidesDNA Repeat ExpansionDrosophilaEukaryotic Initiation Factor-1Frontotemporal DementiaHumansNeuronsProtein BiosynthesisC9orf72 ProteinDipeptidesEukaryotic Initiation Factor-1eukaryotic peptide initiation factor-1AALSC9orf72DipeptideDrosophilaFTD

Identifiers

PMID30604225
PMCPMC6514073
OpenAlexW2907244330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.